These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30174282)

  • 1. Association of blood IgG with tumor necrosis factor-alpha and clinical course of chronic lymphocytic leukemia.
    Spaner DE; Venema R; Huang J; Norris P; Lazarus A; Wang G; Shi Y
    EBioMedicine; 2018 Sep; 35():222-232. PubMed ID: 30174282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional sphingosine-1 phosphate receptor-1 is reduced by B cell receptor signaling and increased by inhibition of PI3 kinase δ but not SYK or BTK in chronic lymphocytic leukemia cells.
    Till KJ; Pettitt AR; Slupsky JR
    J Immunol; 2015 Mar; 194(5):2439-46. PubMed ID: 25632006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
    Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
    Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous immunoglobulin replacement for treatment of humoral immune dysfunction in patients with chronic lymphocytic leukemia.
    Mustafa SS; Jamshed S; Vadamalai K; Ramsey A
    PLoS One; 2021; 16(10):e0258529. PubMed ID: 34653210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
    Rosati E; Sabatini R; Tabilio A; Di Ianni M; Bartoli A; Marconi P
    Leuk Res; 2005 Jul; 29(7):829-39. PubMed ID: 15927678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
    Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
    Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Zou YX; Zhu HY; Li XT; Xia Y; Miao KR; Zhao SS; Wu YJ; Wang L; Xu W; Li JY
    Hematol Oncol; 2019 Oct; 37(4):392-400. PubMed ID: 31420873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
    Del Papa B; Baldoni S; Dorillo E; De Falco F; Rompietti C; Cecchini D; Cantelmi MG; Sorcini D; Nogarotto M; Adamo FM; Mezzasoma F; Silva Barcelos EC; Albi E; Iacucci Ostini R; Di Tommaso A; Marra A; Montanaro G; Martelli MP; Falzetti F; Di Ianni M; Rosati E; Sportoletti P
    Clin Cancer Res; 2019 Dec; 25(24):7540-7553. PubMed ID: 31578228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of interleukin-6 and interleukin-8 with poor prognosis in elderly patients with chronic lymphocytic leukemia.
    Yoon JY; Lafarge S; Dawe D; Lakhi S; Kumar R; Morales C; Marshall A; Gibson SB; Johnston JB
    Leuk Lymphoma; 2012 Sep; 53(9):1735-42. PubMed ID: 22475215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence.
    Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
    Blood Adv; 2024 Aug; 8(16):4239-4249. PubMed ID: 38904477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia.
    Wiestner A
    Haematologica; 2015 Dec; 100(12):1495-507. PubMed ID: 26628631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progression.
    Criado I; Muñoz-Criado S; Rodríguez-Caballero A; Nieto WG; Romero A; Fernández-Navarro P; Alcoceba M; Contreras T; González M; Orfao A; Almeida J;
    Haematologica; 2017 Jul; 102(7):1238-1246. PubMed ID: 28385786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
    PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
    Link H; Kerkmann M; Holtmann L; ;
    Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia.
    Naseraldeen N; Michelis R; Barhoum M; Chezar J; Tadmor T; Aviv A; Shvidel L; Litmanovich A; Shehadeh M; Stemer G; Shaoul E; Braester A
    Front Immunol; 2020; 11():603569. PubMed ID: 33643290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune Reconstitution after BTKi Treatment in Chronic Lymphocytic Leukemia].
    Wang YL; Tang PX; Chen KL; Guo GY; Long JL; Zou YQ; Liang HY; Xu ZS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):1-5. PubMed ID: 38387891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.
    Fiorcari S; Maffei R; Audrito V; Martinelli S; Ten Hacken E; Zucchini P; Grisendi G; Potenza L; Luppi M; Burger JA; Deaglio S; Marasca R
    Oncotarget; 2016 Oct; 7(40):65968-65981. PubMed ID: 27602755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival response to B-cell receptor ligation is restricted to progressive chronic lymphocytic leukemia cells irrespective of Zap70 expression.
    Deglesne PA; Chevallier N; Letestu R; Baran-Marszak F; Beitar T; Salanoubat C; Sanhes L; Nataf J; Roger C; Varin-Blank N; Ajchenbaum-Cymbalista F
    Cancer Res; 2006 Jul; 66(14):7158-66. PubMed ID: 16849562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia.
    Friedrichs B; Siegel S; Kloess M; Barsoum A; Coggin J; Rohrer J; Jakob I; Tiemann M; Heidorn K; Schulte C; Kabelitz D; Steinmann J; Schmitz N; Zeis M
    J Immunol; 2008 May; 180(9):6374-84. PubMed ID: 18424761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.